Moteur de recherche d’entreprises européennes
Financement de l’UE (2 870 878 €) : Faire progresser le développement et la mise en œuvre de l’hologénomique dans les sciences biologiques Hor17/07/2024 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Faire progresser le développement et la mise en œuvre de l’hologénomique dans les sciences biologiques
Basic biology as well as applied fields such as agrobiology, biomedicine or biotechnology are undergoing a revolution driven by the realisation that microorganisms impact virtually all biological processes. Microorganisms associated with complex organisms are no longer considered passive passengers but active crews that continuously interact with their host to shape a wide range of biological functions that play a key role in major basic and applied processes. The application of the newest high throughput molecular technologies to address such interplay has given rise to the novel field of hologenomics, which entails the joint analysis of host genomes and microbial metagenomes with the aim of understanding the impact of host-microbiota interactions in basic and applied biological processes. The DN HoloGen has been conceived to lead the development and practical implementation of hologenomics in order to gain a more comprehensive understanding of host-microbiota interactions, and their impact in both basic and applied areas with direct relevance to many of the global societal challenges. We propose to form an unprecedented multidisciplinary and scientifically sound training network by bringing together top researchers with theoretical knowledge on symbiosis biology, microbial ecology, animal evolution, animal production and biomedicine, as well as practical expertise in large- scale (meta)genomics, DNA sequence analysis, metabolomics, computational biology and biological systems modelling. We anticipate that the research results will be (i) of academic relevance through development of new analytical frameworks and understandings of host-microbiome interactions, (ii) of direct relevance to the portfolios of the industrial partners, and (iii) through these portfolios stand to benefit the European Research and Innovation community.
| Aluke Ltd. | ? |
| AFEKTA TECHNOLOGIES Ltd. | 286 488 € |
| Consorcio para La Explotacion del Centro Nacional de Analisis Genomico | 251 971 € |
| Katholieke Universiteit Leuven | 262 620 € |
| Kobenhavns Universitet | 603 576 € |
| Norges Miljo-og Biovitenskapelige Universitet | 893 246 € |
| TURUN YLIOPISTO | 572 976 € |
https://cordis.europa.eu/project/id/101169005
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Aluke Oy, Helsinki, Finlande.